prognost signific CA half-lif patient ovarian cancer primari chemotherapi surgic cytoreduct patient advanc epitheli ovarian cancer serial serum CA level surgic cytoreduct multi-ag chemotherapi cisplatin-contain regimen half-lif day prolong overal surviv patient disease-fre surgic surveil procedur normal serum CA level u/ml day primari oper improv surviv 